Quantum-Si (NASDAQ:QSI) Stock Rating Lowered by Wall Street Zen

Quantum-Si (NASDAQ:QSI) was downgraded by research analysts at Wall Street Zen from a “hold” rating to a “sell” rating in a report released on Monday, Wall Street Zen reports.

Other equities research analysts also recently issued reports about the company. Alliance Global Partners restated a “buy” rating on shares of Quantum-Si in a research note on Friday, August 14th. Weiss Ratings raised shares of Quantum-Si from a “sell (e+)” rating to a “sell (d-)” rating in a report on Thursday, September 24th. Finally, HC Wainwright set a $4.00 price objective on shares of Quantum-Si in a report on Friday, October 9th. Two research analysts have rated the stock with a Buy rating, one has given a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, Quantum-Si has a consensus rating of “Hold” and a consensus price target of $2.50.

Quantum-Si Price Performance

NASDAQ QSI opened at $1.16 on Monday. The stock has a market capitalization of $253.90 million, a price-to-earnings ratio of -2.52 and a beta of 3.21. Quantum-Si has a 1-year low of $0.69 and a 1-year high of $2.52. The business’s fifty day moving average price is $0.93 and its 200-day moving average price is $0.92.

Quantum-Si (NASDAQ:QSI) last issued its quarterly earnings data on Thursday, August 13th. The company reported ($0.11) EPS for the quarter, hitting the consensus estimate of ($0.11). The company had revenue of $0.34 million during the quarter, compared to analyst estimates of $0.30 million. Quantum-Si had a negative return on equity of 47.12% and a negative net margin of 6,138.26%. Equities research analysts anticipate that Quantum-Si will post -0.47 EPS for the current year.

Hedge Funds Weigh In On Quantum-Si

A number of institutional investors have recently bought and sold shares of QSI. IPG Investment Advisors LLC bought a new stake in Quantum-Si during the second quarter valued at about $27,000. Hollencrest Capital Management increased its position in Quantum-Si by 301.1% in the first quarter. Hollencrest Capital Management now owns 40,111 shares of the company’s stock worth $31,000 after buying an additional 30,111 shares in the last quarter. Corient Private Wealth LP purchased a new position in Quantum-Si during the second quarter valued at approximately $34,000. Green Alpha Advisors LLC purchased a new stake in shares of Quantum-Si in the second quarter worth $41,000. Finally, WINTON GROUP Ltd purchased a new position in shares of Quantum-Si during the 2nd quarter valued at $67,000. 39.90% of the stock is owned by institutional investors.

Quantum-Si Company Profile

Quantum-Si Incorporated (NASDAQ:QSI) is a life sciences technology company focused on advancing proteomics, the study of proteins and their functions. The company develops tools intended to make protein analysis more accessible, scalable and cost-effective for researchers, pharmaceutical companies, biotechnology firms and academic institutions.

Its primary offering is the Platinum platform, which combines a benchtop protein sequencing instrument with single-use consumables and software.